Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1826 to 1850 of 2502

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetesIPG518
Implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantationIPG516
Insertion of endobronchial nitinol coils to improve lung function in emphysemaIPG517
The PediGuard for placing pedicle screws in spinal surgeryMIB26
The Juxta CURES adjustable compression system for treating venous leg ulcersMIB25
Smoking: reducing and preventing tobacco useQS82
Alcohol: preventing harmful use in the communityQS83
Physical activity: for NHS staff, patients and carersQS84
Medicines management in care homesQS85
Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndromeTA335
Empagliflozin in combination therapy for treating type 2 diabetesTA336
Rifaximin for preventing episodes of overt hepatic encephalopathyTA337
Digital ulcers: sildenafilESUOM42
Clostridium difficile infection: risk with broad-spectrum antibioticsESMPB1
Excess winter deaths and illness and the health risks associated with cold homesNG6
Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomesNG5
The Epidrum for aiding access to the epidural spaceMIB23
Shiley Endotracheal Tube with TaperGuard Cuff for intensive care patients at risk of ventilator‑associated pneumoniaMIB22
The OraQuick HCV point‑of‑care test for rapid detection of hepatitis C virus antibodiesMIB24
VibraTip for testing vibration perception to detect diabetic peripheral neuropathyMTG22
Safe midwifery staffing for maternity settingsNG4
Inflammatory bowel diseaseQS81
Bladder cancer: diagnosis and managementNG2
Regorafenib for metastatic colorectal cancer after treatment for metastatic disease (terminated appraisal)TA334
Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapyTA329

Results per page

  1. 10
  2. 25
  3. 50
  4. All